Inventor · disambiguated record
David M. Simpson
Also filed as: SIMPSON DAVID · SIMPSON DAVID M · SIMPSON DAVID MICHAEL
14 granted patents·12 pending applications·306 citations·filing 1993–2024
93Inventor score
Files withIGEN INC5WELLSTAT THERAPEUTICS CORP5IGEN INT INC4PHARMA CINQ LLC3BEIGENE SWITZERLAND GMBH2
Top patents by PatentIndex Score
26 records- 0190US6218519B1Compounds and methods for the selective treatment of cancer and bacterial infectionsPRO NEURON INC·Filed 1996·Granted Apr 17, 2001·138 cites·44 claims
- 0286US10934284B2Aminoquinazoline compounds having anti-inflammatory, antifungal, antiparasitic, and anticancer activityWELLSTAT THERAPEUTICS CORP·Filed 2019·Granted Mar 2, 2021·2 cites·7 claims
- 0384US10030015B2Amine compounds having anti-inflammatory, antifungal, antiparasitic, and anticancer activityWELLSTAT THERAPEUTICS CORP·Filed 2014·Granted Jul 24, 2018·3 cites·17 claims
- 0481US2025034139A1Amine compounds having anti-inflammatory, antifungal, antiparasitic, and anticancer activityPHARMA CINQ LLC·Filed 2024·Application pending·0 cites
- 0577US6346599B1Biodegradable lactone copolymersUNION CARBIDE CHEM PLASTIC·Filed 1998·Granted Feb 12, 2002·37 cites·18 claims
- 0674US6297349B1Condensation copolymers having supressed crystallinityUNION CARBIDE CHEM PLASTIC·Filed 1999·Granted Oct 2, 2001·27 cites·21 claims
- 0771US5597573ALipid-A analogs: new monosaccharide and disaccharide intermediates for eliciting therapeutic antibodies and for antitumor and antiviral activitiesIGEN INC·Filed 1995·Granted Jan 28, 1997·28 cites·6 claims
- 0870US12139483B2Imidazoquinolyl compounds having anti-inflammatory, antifungal, antiparasitic, and anticancer activityPHARMA CINQ LLC·Filed 2021·Granted Nov 12, 2024·0 cites·19 claims
- 0968US2025057821A1Methods of treating myeloid malignancies using bcl-2 inhibitorBEIGENE SWITZERLAND GMBH·Filed 2024·Application pending·0 cites
- 1066US6258360B1Prodrugs activated by targeted catalytic proteinsIGEN INT INC·Filed 1994·Granted Jul 10, 2001·24 cites·13 claims
- 1162US2024122179A1Auxinic herbicides and methods of use thereofCORTEVA AGRISCIENCE LLC·Filed 2022·Application pending·0 cites
- 1259US2018298000A1Aminoquinoline compounds having anticancer activityWELLSTAT THERAPEUTICS CORP·Filed 2018·Application pending·0 cites
- 1358US5593969ALipid-A analogs: monosaccharide and dissaccharide compounds for inhibiting binding of lipid A receptors to lipid A receptorsIGEN INC·Filed 1993·Granted Jan 14, 1997·23 cites·4 claims
- 1457US6702705B1Prodrugs activated by targeted catalytic proteinsIGEN INT INC·Filed 1995·Granted Mar 9, 2004·11 cites·71 claims
- 1557US2024122932A1Methods of Treating B-Cell Malignancy Using Bcl-2 InhibitorBEIGENE SWITZERLAND GMBH·Filed 2023·Application pending·0 cites
- 1651US2023416292A15'-O-Phenylacetyluridine and therapeutic useWELLSTAT THERAPEUTICS CORP·Filed 2021·Application pending·0 cites
- 1750US2023416244A1Imidazoquinoline compound having anti-inflammatory, antifugal, antiparasitic, and anticancer activityWELLSTAT THERAPEUTICS CORP·Filed 2021·Application pending·0 cites
- 1849US2024158431A1Compositions and compounds for co-delivery of uridine and ketoleucinePHARMA CINQ LLC·Filed 2022·Application pending·0 cites
- 1947US5891648AReaction-based selection for expression of and concentration of catalytic moietiesIGEN INC·Filed 1996·Granted Apr 6, 1999·6 cites·4 claims
- 2043US2004202603A1Functionalized nanotubesHYPERION CATALYSIS INT·Filed 2004·Application pending·0 cites
- 2143US2005123533A1Prodrugs activated by targeted catalytic proteinsFiled 2003·Application pending·0 cites
- 2242US2022143157A1Novel uses of botulinum neurotoxin for the treatment of tremorMERZ PHARMA GMBH & CO KGAA·Filed 2020·Application pending·0 cites
- 2342US2003096765A1Prodrugs activated by targeted catalytic proteinsIGEN INC·Filed 2002·Application pending·0 cites
- 2440US5631137AReaction-based selection for expression of and concentration of catalytic moietiesIGEN INC·Filed 1995·Granted May 20, 1997·3 cites·7 claims
- 2539US6177270B1Reaction-based selection for expression of and concentration of catalytic moietiesIGEN INT INC·Filed 1999·Granted Jan 23, 2001·2 cites·44 claims
- 2639US6121007AReaction-based selection for expression of and concentration of catalytic moietiesIGEN INT INC·Filed 1996·Granted Sep 19, 2000·2 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when David M. Simpson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →